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Introduction
This article reviews the current literatureregarding HIV and erectile dysfunction. Thearticle will explore why erectile dysfunction is
more common in men who are HIV positive as appose
to men who do not have HIV. A detailed review of
the current literature in the form of a scoping review
was undertaken to explore the current links between
HIV and erectile dysfunction. Only literature that has
meet the inclusion and exclusion criteria will be
included in this article. Themes that emerge from the
literature will be grouped together in order for
recommendations to be drawn.
Why was the review performed?
The initial idea behind this review emerged from a
lack of understanding by the first author with respect
to this field of nursing and anecdotal evidence from
colleagues that nurses may not have the knowledge,
or be managing erectile dysfunction in practice, and
instead refer such patients to the medical team for
care and management. This article forms part of the
first author’s MSc dissertation.
Why is this an issue in clinical
practice?
With increasing numbers of people living with HIV,
and as HIV becomes a long-term condition, the role
of the nurse within this disease area is changing.
There is a growing need to find ways to support
nurses within clinical practice to manage erectile
dysfunction.
What is erectile dysfunction and how
much of an issue is it in practice?
Erectile dysfunction (ED) is typically defined as the
inability to achieve or maintain an erection for
satisfactory sexual activity [1], with an incident rate
in the general population living without HIV ranging
from 26 cases per 1000 men in the USA [2] to 39 per
1000 cases in Finland [3,4] and finally 66 cases per
1000 in Brazil [5]. Incidence rates increased across all
of these studies with age. Men living with HIV (MLWH)
are statistically more likely to suffer from ED than men
without HIV [6]. Cases of sexual dysfunction linked




The literature was reviewed using the following search
terms: human immunodeficiency virus; HIV; acquired
immunodeficiency syndrome; AIDS; erectile
dysfunction; sexual dysfunction; management; and
nursing/nurse. Numerous databases were searched
including CINAHL Complete, Academic Search
Complete, Medline and PsychINFO. The Cochrane
Library was also searched and one suitable article
was located and although it did not prove relevant
in the field of nursing or medical management, it did
provide detailed statistics about prevalence of ED in
people living with HIV (PLWH).
Manual searching of journals including HIV Nursing,
HIV Medicine, AIDS Care, HIV & AIDS Review,
Southern African Journal of HIV Medicine, African
Journal of AIDS Research, AIDS and Behavior, AIDS
Patients Care and STDs, AIDS Research and Therapy
and AIDS Research and Treatment, allowed for
additional articles to be added to the review. It is
important to remember that key journal searches are
useful to add further articles to the review [8].
A search of the academic textbooks available was
also undertaken to identify texts that may be useful
for nurses in their education on HIV and ED. Finally,
a search of the grey literature was performed to locate
relevant data that may be of benefit and not located
during traditional searching. The advantage of
searching the grey literature is to broaden the scope
to more appropriate studies, therefore, providing a
complete review of the relevant literature [9]. Google
Scholar can be useful in this situation and may add
additional resources to the literature search. Additional
articles can be added to the review from back-
chaining and utilising the feature in Google Scholar
entitled ‘cited by’. This function allows newly-published
data that has used previously identified studies to be
added to a review. This is often referred to as ‘berry
picking’ and can include reviewing an author’s other
publications [10]. Finally, colleagues and specialists
in the field from the National HIV Nursing Association
were approached about ‘HIV and erectile dysfunction’
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to further add any additional resources or advice to
the study. This process can generate additional sources
of information and provide additional insight in to the
chosen topic [11].
The literature review process is a valuable stage in
the research process as it shows what studies have
previously been undertaken, it is a way of learning
about existing theories and ideas, allowing for new
research approaches to develop from the learning
and finally justifies the research project [12]. A scoping
review was decided upon due to the complexity of
words used within the chosen topic. Previous studies
have approached their research in this way [13], and
such a review allows for a broader range of literature
to be searched [14]. Furthermore, it aims for breadth
and comprehensiveness rather than for depth in the
research [8].
The process for undertaking a scoping review can be
divided in to five stages [8]:
Stage 1: Identifying the research question
Stage 2: Identifying relevant studies
Stage 3: Study selection
Stage 4: Charting the data
Stage 5: Collating, summarising and reporting the
results
The first aim, and fundamentally important part, of
the study is to identify a suitable research question
for the scoping review. The question for the purpose
of this scoping review was:
What is known from the existing literature
about MLWH and erectile dysfunction and the
role the HIV nurse plays?
The search strategy loosely mirrored a piece of
research published in the Journal of Advanced
Nursing and this article follows a logical and
constructive way of searching the literature [15]. Figure
1 describes the search strategy and findings. Initial
searching of CINAHL Complete, Academic Search
Complete, Medline and PsychINFO using key words
discussed earlier found 63 results. Once duplicates had
been removed from an initial search of 63, 38 articles
were left. The 38 articles had their abstracts reviewed
and selected if they met the inclusion criteria, which
were that the articles must:
■ Report, investigate or contain information relevant
to the topic
■ Be published 2005–2015
■ Be English language studies only
■ Be studies dedicated to men, HIV and ED
From this review, 11 articles were selected, however,
only eight were accepted for final inclusion in the
review, again following the inclusion criteria. Back-
chaining allowed another six papers to be identified
for review and two of these were carried forward into
the study. In total 10 papers were included for the
final review (Table 1). One additional study, found
in the Cochrane Library had already been included
in the study. Grey searching and utilising Google
Scholar did not locate any additional suitable articles,
nor did manually searching the suggested specific
journals mentioned earlier.
Using recent sources of information that have been
published in the last 10 years allows for current or
fairly recent information to be used within the study
and is widely recommended in the research. As a
result of this process 10 articles in total were selected
for review and were explored.
Results
Table 1 shows the studies and demonstrates that they
are from an international arena with work published
pan-Europe (including the UK), in Belgium, Italy,
Mexico, Spain, Switzerland and the USA. Sample size
varies from 90 to 4064 MLWH, and two of the studies
used a comparison with men not living with HIV. All
of the articles were published in peer-reviewed
journals and were published 2006–2014. All used a
quantitative approach, mainly using the International
Index of Erectile Dysfunction questionnaire or an
adapted version. Most of the studies looked at
heterosexual men or men who have sex with men
(MSM), although one study was dedicated just to
MSM.
A number of key topics were highlighted from the
review that show ED in MLWH is more common and,
furthermore, the question of why is not simple to
answer. Cholesterol levels; a person’s mental health
status; their CD4 count at diagnosis and present CD4
count; ART and the length of time a person has been





Exclusion by title, abstract and duplicate
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Figure 1: Search strategy and findings.
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on treatment; the type of sexual activity; and finally;
testosterone levels all play roles and may influence
whether a person is more likely to suffer from ED. The
studies themselves contradict each other and
subsequent studies have been unable to replicate
earlier studies. The cause of ED is still poorly understood
in MLWH and this review highlights that further
research is needed in the area to try to answer such
a question. Conclusively, health professionals need
to screen patients for ED as it is highlighted in several
of the studies that a higher rate of ED is noted, yet,
patients have not been offered appropriate treatment
(see later).
Studies that connect HIV with ED demonstrated the
complexity and lack of understanding about what
is more likely to cause ED in MLWH. Each study
demonstrated an increase or high prevalence of ED
ranging from 32.9% [16] to 74% reporting mild
symptoms [4].
Dyslipidaemia
Dyslipidaemia (raised cholesterol levels) was
associated in one study as the only potential link to
ED for MLWH however the article highlights that
this needs to be studied further [17]. Although this
study acknowledges the role medications (particularly
statins – cholesterol lowering drugs) play, they
were not evaluated with regards to their effects on
ED or how they may improve ED. This may alter
the findings of this study specifically as the conclusions
highlight that higher levels of cholesterol are
associated with ED. It was the only study to highlight
a connection between HIV, ED and dyslipidaemia.
However, other studies of men without HIV have
linked raised cholesterol with ED, even when men
are taking statins [18,19], therefore, showing there
would appear to be a clear link, however, this may
not be the reason why MLWH have a higher
incidence of ED.
Mental health
Four of the studies linked ED with some aspect of
mental health. Interestingly, one study showed in its
statistical analysis of a large multivariable study of
711 MLWH, an association between antidepressants/
other psychotropic medication use and ED [16].
However, this study failed to show or provide reason
why this may be; and so, as noted in their limitations,
this may be a spurious association (due to the large
number of variables).
In the Swiss cohort study, a connection between ED
and depression was highlighted showing the role
that psychiatric and psychosocial factors play in
healthy sexual function [20]. The study did not explore
further or provide reasons why this may be the
case, therefore, additional analysis is required to
investigate this. The authors self-report multiple
limitations in the study, mainly that only one question
was asked about ED and that the validated,
International Index of Erectile Dysfunction
Questionnaire was not used.
In a study of 158 men, a significant link was found
between anxiety and depression with ED and how
feelings of guilt, principally about how the men may
have acquired their HIV status, may be a
psychological factor that is inadvertently affecting
sexual function [21]. Furthermore, this psychological
factor may go on to explain higher rates of sexual
dysfunction in MSM, which has been reported in other
studies [22,23].
Crum-Cianflone et al. used a self-completed
questionnaire from 300 MLWH [24]. Participants
completed the International Index of Erectile
Dysfunction Questionaire and the Beck Depression
Inventory, which is widely used to diagnose
depression and anxiety [25]. The study showed 40%
of men with ED were depressed compared to 12% of
men who did not have ED. Strikingly, the authors note
that each condition, namely, ED and depression, may
exacerbate each other and it is unclear in that case
which one is the primary problem. Early diagnosis
and treatment of depression for MLWH may be
beneficial in improving or preventing ED, although,
more research is needed to support this.
CD4 count
Crum-Cianflone et al. [24] go on to report how the
CD4 count is predictive of ED. The study clearly
showed a lower nadir CD4 count (the level of the
immune system at HIV diagnosis) in patients is more
likely to mean they may have ED. Put simply, this
means the sooner a patient is diagnosed with HIV,
the higher the CD4 count will be, meaning they may
be less likely to develop ED, this reinforces the
argument for early diagnosis and treatment.
Commencing treatment early and reducing the
likelihood of the CD4 count dropping by starting ART
may be beneficial in preventing ED and starting
treatment early has been shown to reduce AIDS-
related problems [26]. In addition to this, low current
CD4 count is predictive of ED, again supporting early
commencement of ART.
Ende et al. [4] reported higher rates of ED in their
study (n=118). Their findings did not demonstrate
any correlation between current CD4 count and
whether the men were likely to have ED contradicting
Crum-Cianflone et al.’s study. Interestingly, Ende et
al. did not demonstrate any correlation between
any of the study’s variables, which included age,
whether currently on ART, opportunistic infections
or median testosterone levels; this may have been
due to a lack of ‘power’ from the relatively small
sample size.
Ende et al’s study identified that some men were
undertreated for ED with only 11% out of the 74% of
men in the study who reported ED, being treated.
They rationalised this by discussing that treating ED
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with phosphodiesterase type 5 inhibitor ([PDE5] drugs
to help achieve an erection) may lead to risky sexual
behaviour. This may prevent the clinical team
prescribing these medications to avoid the onward
transmission of HIV. This is supported by another
study of 413 participants that suggested that PDE5
drugs prescribed to MLWH may lead to ‘potentially
transmitting sexual risk behavior’ [27]. However, with
the advances in ART treatment and, furthermore,
the fact that HIV treatment lowers HIV viraemia
(amount of HIV in the body) this will make an
individual with HIV extremely unlikely to transmit
HIV, if they are complying with treatment regimens
[28]. This should, therefore, no longer be an issue.
Interestingly, Ende et al. do support the prescribing
of PDE5 inhibitors but only after advice on; safe sex,
condom use, sexually transmitted infections and
education about the risks.
Underuse of PDE5 inhibitors (such as
Cialis and Viagra)
Moreno-Pérez et al. [29], discuss how underused PDE5
inhibitors are in their study of 90 patients, of which
47 reported suffering with ED. Of these only 11 had
actually tried PDE5 inhibitors as a treatment option
but remarkably nine of these (81%) reported that they
had been effective, showing the lack of use in clinical
practice when the drug appears to be helping. Despite
the lack of randomised control trials of MLWH and
the efficacy of PDE5 inhibitors it is widely accepted
as a first line therapy to treat ED [29].
Unsurprisingly, De Ryck et al. discuss that MLWH and
ED are more likely to use PDE5 inhibitors than men
without ED; in spite of this only 7% of men reported
using this medication either most times or almost
always when engaging in sexual activity [30]. This
again highlights the under use of PDE5 inhibitors by
MLWH. De Ryck et al. goes on to discuss how
screening of all MLWH should take place to identify
ED. Clinical teams need to be pro-active rather than
reactive in this area. Once identified, PDE5 inhibitors
can be prescribed, but, in the interests of public safety
recommending it should be accompanied by safer
sex counselling [30].
HIV Treatment
The use of HIV ART has long been associated with
ED, particularly one group of ART, namely the
protease inhibiting (PI) drugs [31]. Only one study out
of the ten used in this scoping review, highlighted that
PIs are linked to ED [29], and although Moreno-Pérez
et al.’s study does highlight that a PI may be
associated with an increased likelihood of ED, it is a
small study of 90 patients of whom only 39 were
actually taking a PI; their study acknowledges the
small scale of the sample within its limitations.
Asboe et al. within their study, note that the use of
ART per se does not influence ED but the length of
time someone is on treatment does [16]. It is significant
when someone has been on treatment for longer than
81 months, but this could not be attributed to PIs alone
and instead was considered to be related to ART in
general. Interestingly, within their study they report
that some participants stopped or switched ART due
to ED. Most who did, came off a PI-based regime and
some did report improvement, the authors stress that
they cannot assume it was the ART that was
responsible for ED. In contrast, Romero-Velex et al.
note there is no correlation between any groups of
drugs or the length of time that the person takes them
for and ED [17].
Wang et al. report no correlation between ED and
any group of ART although they do mention two
specific drugs out of 25 (zalcitabine and enfuvirtide)
that may be slightly more likely to be correlated with
ED, although neither of them are used frequently
today [20]. Crum-Cianflone et al. report no correlation
between ED and ART. Their study looked specifically
at groups of drugs and individual drugs, and no
significant association was seen [24]. It was first
reported that PIs had a link to ED but it is clear that
this has not been clearly identified since to be
significant [32].
Sexual activity
Romero-Velex et al. recognise in terms of prevalence
of ED that there is no difference between MSM living
with HIV, or heterosexual men living with HIV [17].
Zona et al. also reported no difference between MSM
and heterosexual men but suggested that the
International Index of Erection Function probably fails
when comparing results from heterosexual men and
MSM [33]. The problem they suggested is that MSM
require a higher penile rigidity for anal penetration
and therefore suggest that this group of men would
report worse ED symptoms. By contrast, Asboe et al.
report more heterosexual men are likely to have ED
than homosexual men [16].
Shindel et al. compare men who have sex with men
living with HIV, with men who have sex with men
without HIV. They reported a higher incidence of ED
in patients with progressive HIV (advanced HIV status)
and men that were aged above 40 years of age [34].
They hypothesised that ED occurs around 10–15 years
sooner in men with HIV than without HIV. In their
study they did not assess whether ART impacts ED
and this is highlighted as a limitation of the study.
Testosterone levels
Zona et al. reported that hypogonadism (low
testosterone levels) is to be linked to ED in MLWH [33].
Erectile dysfunction has been linked to hypogonadism
as testosterone is required for normal erection,
although, ED has been seen in men with normal
testosterone levels too [35]. Furthermore, in the pre-ART
availability era hypogonadism was seen frequently
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[7], however, since the introduction of ART, levels of
hypogonadism appear to be reducing [36]. Although,
Crum-Cianflone et al. show no correlation between
low testosterone levels, and current, past or cumulative
use of ART [24], in contrast, De Ryck et al. present
18 out of 49 men in their study who had their
testosterone levels checked and were shown to be
testosterone deficient [30]. Furthermore, they suggest
routine screening of ED using a tool such as the
International Index of Erection Function and
subsequently testosterone level testing. If low
testosterone is detected it would be beneficial to
consider testosterone replacement alongside PDE5
inhibitors.
Discussion
The differences identified within in all of the studies
highlights that ED in MLWH are a multifaceted issue
with no clear answers emerging. The variances
seen can be explained by the different study designs,
study populations and the changing tools used to
evaluate ED. Cholesterol levels; a person’s mental
health status; their CD4 count at diagnosis and
present CD4 count; ART and the length of time a
person has been on treatment; type of sexual
activity; and finally testosterone levels all play
roles that may influence whether a person is more
likely to suffer from ED. Of note none of the studies
reported the role of the nurse in the management
of ED but some of the studies did note that ‘healthcare
professionals’ involved in HIV care should screen
patients for ED. From the evidence presented above
it is clear that screening should be carried out
within clinical practice, however from the literature
reviewed it suggested that it is unclear as to whether
this is happening and further research is required
to establish this and clarify the current situation
within clinical practice.
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Renal disorders and HIV: answers to
the self-assessment quiz
1. The correct answer is d i.e. the kidneys
receive approximately 20% of cardiac output
2. The correct answer is b i.e. filtration is the
main function of the glomerulus
3. The equation takes into account the serum
creatinine, age, ethnicity and gender
4. Answers a and c are correct
5. All of the answers are possible causes of
glomerulonephritis
6. An eGFR<15 is found in stage 5 i.e. end-stage
renal disease
7. The correct answer is the blood urea nitrogen
result or BUN
8. Answer b is correct
9. The statement is ‘true’
10. You could answer any three of the following:
excessive use of NSAIDs, recreational drug
use, uncontrolled hypertension, uncontrolled
diabetes, cigarette smoking, dehydration or
high protein diet.
11. Answers a, b, d are correct. The kidneys are
usually enlarged on ultrasound.
12. Answer d is the only correct criteria according
to current British Transplantation Society
guidelines
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